⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
CTOR News
Citius Oncology, Inc. Common Stock
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc. (NASDQ: CTOR)
prnewswire.com
CTOR
Citius Oncology, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
prnewswire.com
CTOR
CTXR
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
prnewswire.com
CTXR
CTOR
Citius Oncology Announces Closing of $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
prnewswire.com
CTOR
CTXR
Citius Oncology Announces $18 Million Concurrent Registered Direct Offering and Private Placement Priced At-The-Market Under Nasdaq Rules
prnewswire.com
CTOR
CTXR
Citius Oncology Expands LYMPHIR™ Distribution to Turkey and Middle East Countries Through Exclusive Agreement with Er-Kim
prnewswire.com
CTOR
CTXR
Breakthrough Therapies Advance as Rare Disease Burden Intensifies Across Aging Populations
globenewswire.com
SNGX
AMGN
FOLD
CTOR
TNXP
Citius Oncology Announces U.S. Commercial Launch of LYMPHIR™, a Novel Cancer Immunotherapy for Cutaneous T-Cell Lymphoma (CTCL)
prnewswire.com
CTOR
CTXR
Citius Oncology to Exhibit at the 67th American Society of Hematology (ASH) Annual Meeting
prnewswire.com
CTOR
CTXR
Citius Oncology to Advance Commercial Launch of LYMPHIR™ with Verix AI Integration
prnewswire.com
CTOR
CTXR